Ergotamine

CHEMBL442 Phase 4 승인됨 Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

581.7 g/mol

LogP

2.0

Phase

4

This medication works by constricting dilated blood vessels in the brain and blocking pain pathways to relieve migraine and cluster headache attacks. It is most effective when taken at the very start of a headache.

분자량

581.7000 g/mol

LogP

2.00

TPSA

118.00 Å²

리핀스키 5의 법칙

통과

치료 영역

Parkinson's Disease Migraine Schizophrenia Stroke Obesity Type 2 Diabetes Hypertension Chronic Pain

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure

Embed this structure

SMILES

CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21

InChI

InChI=1S/C33H35N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)/t21-,25-,26+,27+,32-,33+/m1/s1

Molecular Formula

C33H35N5O5

HBD / HBA

3 / 6

회전 가능 결합

4

무거운 원자

43

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

This medication works by constricting dilated blood vessels in the brain and blocking pain pathways to relieve migraine and cluster headache attacks. It is most effective when taken at the very start of a headache.

Yes, Ergotamine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL442. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 8223. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

환자 친화적 정보를 찾고 계신가요?

Ergotamine PillFYI에서

구조

핵심 데이터

분자식: C33H35N5O5
동의어: 2

외부 링크

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.